$RYAN

ROGERS JOHN W JR purchased $264K of RYAN

ROGERS JOHN W JR purchased 7,500 shares of RYAN SPECIALTY HOLDINGS, INC. (RYAN) at $35.16 ($0.26M total) on 2026-06-10.

Original reporting
SEC EDGAR · ROGERS JOHN W JR
Published Jun 11, 2026, 9:57 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 11, 2026, 10:01 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$RYAN
Bullish
medium confidence
Mentioned
$RYAN
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$RYANBullishLow
01

Why it matters

The newest fact is the director’s open-market purchase amount, price, and post-transaction holdings; it may slightly influence sentiment but does not change fundamentals on its own.

02

Market read

Traders may note the insider buy as a small sentiment input, but there is no new operational or financial catalyst in the text.

03

What to watch

No 10b5-1 plan is cited, but the filing still lacks context (e.g., prior trading history, motivation, or whether other insiders/owners acted).

Relevance 5/10Novelty 6/10Timing: Filed 2026-06-11; purchase dated 2026-06-10.

Background

The article is an SEC EDGAR Form 4 insider transaction disclosure for RYAN Specialty Holdings, Inc.

Company-level read

Ticker impact

$RYANBullishMedium confidence
Context

Director John W. Rogers Jr. filed an SEC Form 4 for an open-market purchase of 7,500 shares of RYAN Specialty at $35.1643/share on 2026-06-10.

Expected impact

Likely limited near-term impact; any effect is more sentiment/positioning than a re-rating catalyst.

Evidence & confidence

The disclosure is a routine Form 4 insider transaction with no accompanying guidance, deal, or regulatory development; size is moderate relative to typical market-moving events.

Market effects

No clear sector read-across; this is company-specific insider activity without operational or regulatory details.

None indicated.

None indicated.

Counterpoint

Insider open-market buys can be driven by diversification, liquidity needs, or pre-planned behavior rather than a strong forward-looking view.

Key entities

  • RYAN Specialty Holdings, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • ROGERS JOHN W JR

    Director who purchased 7,500 shares in an open-market transaction.

Related articles

$RYANMedAI 8/10

Ryan Specialty posts Q2 revenue gain as E&S market slows

Ryan Specialty Holdings, Inc. reported second-quarter 2026 net commissions and fees of $902.7 million, up 7.4% year-over-year. Total revenue for the quarter reached $916.6 million, a 7.2% increase from $855.2 million a year earlier. Organic revenue growth came in at 6.7%, down from 7.1% in the prior-year period. The deceleration continues a trend across multiple quarters as the broader E&S market moderates.

$RYANMed

RYAN SPECIALTY HOLDINGS, INC. (RYAN): Results of Operations and Financial Condition

RYAN SPECIALTY HOLDINGS, INC. (RYAN) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ryan-20260630xex991.htm EX-99.1 RYAN-2026.06.30-EX 99.1 1 RYAN SPECIALTY REPORTS SECOND QUARTER 2026 RESULTS - Total Revenue grew 7.2% year-over-year to $916.6 million - - Organic Revenue Growth Rate* of 6.7% year-over-year - - Net Income of $108.4 million , or $0.33 pe